The market is fragmented, featuring the presence of both industry and non-industry players that are involved in providing proteome profiling services for various applications, claims Roots Analysis

Jordan12

215
views

With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive.

With the growing prominence of peptide-basedtherapeutics and personalized medicine, there is an increased demand for rapid,highly sensitive, and accurate quantification methods to analyze clinicalspecimens. As a result, proteome profiling has become an indispensable part ofmodern drug discovery and development process, as well as disease diagnosis.

To order this 290+page report, which features 50+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/proteome-profiling-services.html

The USD 16 billion(by 2030) financial opportunity within the proteome profiling services markethas been analyzed across the following segments:

§ Application Area

§ Drug Discovery

§ DiseaseDiagnosis

§ Others

§ Type of Sponsor(s)

§ Contract Research Organizations

§ PharmaceuticalCompanies

§ Research andAcademic Institutes

§ Key Geographical Regions

§ North America

§ Europe

§ Asia Pacific

§ Rest of the World

The ProteomeProfiling Services Market, 2020-2030.” report features thefollowing companies, which we identified to be key players in this domain:

§ Biognosys

§ BGI

§ Bioproximity

§ Cell Signaling Technology

§ Creative Biolabs

§ Creative Proteomics

§ Cytomics

§ i-DNA Biotechnology

§ NMI TT Pharmaservices

§ Poochon Scientific

§ Proteomics International

§ Proteome Factory